(19)
(11) EP 4 304 716 A1

(12)

(43) Date of publication:
17.01.2024 Bulletin 2024/03

(21) Application number: 22716610.5

(22) Date of filing: 10.03.2022
(51) International Patent Classification (IPC): 
A61P 11/00(2006.01)
A61P 35/00(2006.01)
C07D 491/18(2006.01)
 A61P 13/12(2006.01)
C07D 471/04(2006.01)
C07D 495/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; C07D 491/18; C07D 495/04; A61P 11/00; A61P 13/12; A61P 35/00
(86) International application number:
PCT/US2022/019759
(87) International publication number:
WO 2022/192545 (15.09.2022 Gazette 2022/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.03.2021 US 202163159063 P

(71) Applicant: Dice Molecules Sv, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • SHARMA, Lalit Kumar
    South San Francisco, California 94080 (US)
  • FATHEREE, Paul Ross
    South San Francisco, California 94080 (US)
  • JACOBSEN, John R.
    South San Francisco, California 94080 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF